CollPlant Biotechnologies (CLGN) Change in Intangibles (2020 - 2022)
CollPlant Biotechnologies' (CLGN) quarterly Change in Intangibles came in at -$42000.0 in Q4 2022, up 73.91% YoY from -$24150.0 in Q4 2021, and down 223.08% on a QoQ basis from -$13000.0 in Q3 2022.
CollPlant Biotechnologies (CLGN) Change in Intangibles (2020 - 2022) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 3 years of Change in Intangibles data on file, last reported at -$42000.0 in Q4 2022.
- Quarterly Change in Intangibles rose 73.91% year-over-year to -$42000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$67000.0 (up 75.46% YoY) and the FY2022 annual result came in at -$42000.0, up 73.91% from the prior year.
- Change in Intangibles eased to -$42000.0 in Q4 2022, from -$13000.0 in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of -$6000.0 in Q1 2022 to a low of -$161000.0 in Q4 2021.
- A 3-year average of -$46888.9 and a median of -$30000.0 in 2021 frame the typical range for Change in Intangibles.
- Annual changes were most pronounced in 2021 — Change in Intangibles slumped 96.34% — and 2022, when it surged 89.29%.
- Tracing CLGN's Change in Intangibles over 3 years: stood at -$82000.0 in 2020, then tumbled by 96.34% to -$161000.0 in 2021, then jumped by 73.91% to -$42000.0 in 2022.
- The last three Change in Intangibles figures came in at -$42000.0 (Q4 2022), -$13000.0 (Q3 2022), and -$6000.0 (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.68 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.26 Mn | 4.26 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -42,000.00 |
| Dec 31, 2022 | -42,000.00 |
| Sep 30, 2022 | -13,000.00 |
| Sep 30, 2022 | -13,000.00 |
| Jun 30, 2022 | -6,000.00 |
| Jun 30, 2022 | -6,000.00 |
| Mar 31, 2022 | -6,000.00 |
| Mar 31, 2022 | -6,000.00 |
| Dec 31, 2021 | -161,000.00 |
| Dec 31, 2021 | -161,000.00 |
| Sep 30, 2021 | -30,000.00 |
| Sep 30, 2021 | -30,000.00 |
| Jun 30, 2021 | -26,000.00 |
| Jun 30, 2021 | -26,000.00 |
| Mar 31, 2021 | -56,000.00 |
| Mar 31, 2021 | -56,000.00 |
| Dec 31, 2020 | -82,000.00 |
| Dec 31, 2020 | -82,000.00 |